FDA 483 - Terumo BCT Ltd - February 07, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Terumo BCT Ltd, a sterile parenteral manufacturer in Larne, United Kingdom, was cited for significant deficiencies during an FDA inspection. Observations included failures in following procedures to prevent microbiological contamination, specifically regarding sterilization validation processes and disinfectant efficacy studies. Additionally, the firm's batch production and control records were found to be incomplete, lacking essential in-process bioburden test results and review instructions.
ID · d1d35841-2276-447f-b925-99e1e87434a8